BioDelivery Sciences International (BioDelivery Sciences International) Total Inventories : $23.7 Mil (As of Dec. 2021)

View and export this data going back to 2002. Start your Free Trial

What is BioDelivery Sciences International Total Inventories?

BioDelivery Sciences International's total inventories for the quarter that ended in Dec. 2021 was $23.7 Mil. BioDelivery Sciences International's average total inventories from the quarter that ended in Sep. 2021 to the quarter that ended in Dec. 2021 was $23.4 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. BioDelivery Sciences International's Net-Net Working Capital per share for the quarter that ended in Dec. 2021 was $0.32.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. BioDelivery Sciences International's Days Inventory for the three months ended in Dec. 2021 was 309.23.

Inventory Turnover measures how fast the company turns over its inventory within a year. BioDelivery Sciences International's Inventory Turnover for the quarter that ended in Dec. 2021 was 0.30.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BioDelivery Sciences International's Inventory-to-Revenue for the quarter that ended in Dec. 2021 was 0.54.

BioDelivery Sciences International Total Inventories Historical Data

The historical data trend for BioDelivery Sciences International's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Total Inventories Chart

BioDelivery Sciences International Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Inventories

Get a 7-Day Free Trial

6.09

5.41

11.31

17.44

23.71

BioDelivery Sciences International Quarterly Data
	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
Total Inventories	Get a 7-Day Free Trial															17.44	16.97	18.66	23.08	23.71

BioDelivery Sciences International Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

BioDelivery Sciences International (NAS:BDSI) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

BioDelivery Sciences International's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2021 is

	Net-Net Working Capital Per Share (Q: Dec. 2021 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(114.309	+	0.75 * 56.867	+	0.5 * 23.711	-	136.774
-	0	-	0)	/	101.536
=	0.32

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BioDelivery Sciences International's Days Inventory for the three months ended in Dec. 2021 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2021 )	/	Cost of Goods Sold (Q: Dec. 2021 )	*	Days in Period
	=	23.393	/	6.903	*	365 / 4
	=	309.23

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

BioDelivery Sciences International's Inventory Turnover for the quarter that ended in Dec. 2021 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2021 )	/	Average Total Inventories (Q: Dec. 2021 )
	=	6.903	/	23.393
	=	0.30

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BioDelivery Sciences International's Inventory to Revenue for the quarter that ended in Dec. 2021 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2021 )	/	Revenue (Q: Dec. 2021 )
	=	23.393	/	43.154
	=	0.54

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

BioDelivery Sciences International Total Inventories Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

BioDelivery Sciences International (BioDelivery Sciences International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (NAS:BDSI) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612

Website

http://www.bdsi.com

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

Executives

James Vollins	officer: See Remarks	C/O BIODELIVERY SCIENCES INTERNATIONAL, 4131 PARK LAKE AVE SUITE 225, RALEIGH NC 27607
Mark A Sirgo	director	C/O BIODELIVERY SCIENCES INTERNATIONAL, 801 CORPORATE CENTER DRIVE -SUITE 210, RALEIGH NC 27607
Broadfin Healthcare Master Fund Ltd	director	C/O 20 GENESIS CLOSE, ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344, GRAND CAYMAN E9 KY1-1108
Kevin Kotler	director	C/O BROADFIN CAPITAL, LLC, 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Mary Theresa Coelho	officer: See Remarks	52 SUNRISE PARK ROAD, NEW HAMPTON NY 43017
Jeffrey Allen Bailey	director, officer: Chief Executive Officer	BIODELIVERY SCIENCES INTERNATIONAL, INC., 4131 PARKLAKE AVE., SUITE 225, RALEIGH NC 27612
Todd C Davis	director	11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
W. Mark Watson	director	324 S. HYDE PARK AVENUE, STE 350, TAMPA FL 33606
Peter Greenleaf	director	ONE MEDIMMUNE WAY, GAITHERSBURG MD 20878
Broadfin Capital, Llc	director	300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Vanila Singh	director	C/O BIODELIVERY SCIENCES INTERNATIONAL, 4131 PARKLAKE AVE., SUITE 225, RALEIGH NC 27612
Scott M. Plesha	officer: See Remarks	1410 SMYTHE ST DANIEL ISLAND SC 29492
Odonnell Francis E Jr	director	BIODELIVERY SCIENCES INTERNATIONAL, INC, 4131 PARKLAKE AVENUE, SUITE #225, RALEIGH NC 27612
Herm Cukier	director, officer: Chief Executive Officer	C/O BIODELIVERY SCIENTES INT., INC. 4131 PARKLAKE AVE, SUITE 225 RALEIGH NC 27612
Thomas B Smith	officer: Chief Medical Officer	BIODELIVERY SCIENCES INTERNATIONAL, INC., 4131 PARKLAKE AVE SUITE 225, RALEIGH NC 27612